Review
doi: 10.18553/jmcp.2006.12.3.265.
Relative value of the NSAIDs, including COX-2 inhibitors and meloxicam
- PMID: 16623613
- PMCID: PMC10437881
- DOI: 10.18553/jmcp.2006.12.3.265
Item in Clipboard
Review
Relative value of the NSAIDs, including COX-2 inhibitors and meloxicam
J Manag Care Pharm.
2006 Apr.
No abstract available
Comment on
-
Gastrointestinal bleeding rates among managed care patients newly started on cox-2 inhibitors or nonselective NSAIDs.J Manag Care Pharm. 2005 Sep;11(7):550-8. doi: 10.18553/jmcp.2005.11.7.550. J Manag Care Pharm. 2005. PMID: 16137212 Free PMC article.
Similar articles
-
Relative safety of meloxicam in NSAID-intolerant patients.Allergy. 1998 Dec;53(12):1231-3. doi: 10.1111/j.1398-9995.1998.tb03854.x. Allergy. 1998. PMID: 9930610 No abstract available.
-
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.Br J Rheumatol. 1998 Sep;37(9):937-45. doi: 10.1093/rheumatology/37.9.937. Br J Rheumatol. 1998. PMID: 9783757 Clinical Trial.
-
Developing a managed care-pharmaceutical research partnership.Manag Care Interface. 1999 Mar;12(3):83-8. Manag Care Interface. 1999. PMID: 10351414 Clinical Trial.
-
Meloxicam--a safer NSAID?Drug Ther Bull. 1998 Aug;36(8):62-4. Drug Ther Bull. 1998. PMID: 9876404 Review. No abstract available.
-
Meloxicam: selective COX-2 inhibition in clinical practice.Semin Arthritis Rheum. 1997 Jun;26(6 Suppl 1):21-7. doi: 10.1016/s0049-0172(97)80049-2. Semin Arthritis Rheum. 1997. PMID: 9219316 Review.
Cited by
-
Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.Health Serv Res. 2008 Feb;43(1 Pt 2):435-50. doi: 10.1111/j.1475-6773.2007.00766.x. Health Serv Res. 2008. PMID: 18199195 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials